DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vincristine (Vincristine) - Anaemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Anaemia (102)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vincristine where reactions include anaemia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 102   Next >>

Possible Vincristine side effects in male

Reported by a physician from United States on 2012-08-22

Patient: male

Reactions: Rectal Haemorrhage, Constipation, Cardiac Disorder, Hospitalisation, Granulocytopenia, Inappropriate Antidiuretic Hormone Secretion, Thrombocytopenia, Cardiac Failure Congestive, Pneumonia, Anaemia, Pancytopenia, Atrial Fibrillation, Febrile Neutropenia, Syncope, Embolism, Sepsis, Dehydration, Asthenia, Mantle Cell Lymphoma Recurrent, Leukopenia, Deep Vein Thrombosis, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1
    Indication: Mantle Cell Lymphoma

Cyclophosphamide
    Dosage: on day 1
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Dosage: on day 1
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Dosage: on day 1
    Indication: Mantle Cell Lymphoma

Leukine
    Dosage: on day 9-15; 250 mcg/m2/day
    Indication: Mantle Cell Lymphoma

Leukine
    Dosage: on day 9-15; 250 mcg/m2/day
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone TAB
    Dosage: on days 1-5
    Indication: Mantle Cell Lymphoma

Prednisone TAB
    Dosage: on days 1-5
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: on day 15; as infusion
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: on day 15; as infusion
    Indication: Mantle Cell Lymphoma

Vincristine
    Dosage: on day 1 (maximum dose: 2mg)
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Dosage: on day 1 (maximum dose: 2mg)
    Indication: Mantle Cell Lymphoma



Possible Vincristine side effects in

Reported by a physician from United Kingdom on 2012-08-10

Patient:

Reactions: Diarrhoea, Anaemia, Dizziness, Pulmonary Mycosis, Lethargy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1500 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-07-04

Doxorubicin HCL
    Dosage: 100 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-07-04

Prednisolone
    Dosage: 100 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-07-08

Rituximab
    Dosage: 750 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-07-04

Velcade
    Dosage: 2.6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-07-04

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-07-04

Other drugs received by patient: Prednisolone; Tramadol HCL; Chlorhexidine Gluconate; Omeprazole; Itraconazole; Acyclovir; Symbicort; Montelukast; Cetraben / 01561901 /; Fluconazole; Nitrofurantoin; Citalopram Hydrobromide; NEO-Mercazole TAB; Cotrim; Ferrous Fumarate; Ventolin; Enoxaparin Sodium; Metoclopramide



Possible Vincristine side effects in male

Reported by a lawyer from United States on 2012-08-03

Patient: male

Reactions: Tinnitus, Femur Fracture, Osteomyelitis, Oral Cavity Fistula, Erythema, Erectile Dysfunction, Neurotoxicity, Hypoaesthesia Oral, Oedema Peripheral, Carpal Tunnel Syndrome, Radiculopathy, Intervertebral Disc Protrusion, Cellulitis, Gingival Bleeding, Pneumonia, Pain in Extremity, Anaemia, Encephalopathy, Otitis Externa, Nasal Septum Deviation, Abscess JAW, Paraesthesia, Osteosclerosis, Rhinitis Allergic, Osteonecrosis, Mental Disorder, Osteoporosis, Pain, Multiple Myeloma, Periodontitis, Overdose, Neuropathy Peripheral, Intervertebral Disc Degeneration, Depression, Injury, Gastrooesophageal Reflux Disease, Pain in JAW, Dyspnoea, Spondylolysis, Spondylolisthesis, Hepatitis Acute, Musculoskeletal Pain, Febrile Neutropenia, Osteolysis, Cognitive Disorder, Deformity, Amnesia, Osteoarthritis, Anxiety, Osteonecrosis of JAW, Heart Rate Increased, Infection

Drug(s) suspected as cause:
Aredia

Thalidomide
    Dosage: 50 mg, qd

Vincristine

Zometa
    Dosage: 4 mg, qmo

Other drugs received by patient: Clonazepam; Dexamethasone; Oxycontin; Tegretol; Neurontin



Possible Vincristine side effects in female

Reported by a physician from Poland on 2012-08-02

Patient: female, weighing 58.0 kg (127.6 pounds)

Reactions: Retroperitoneal Mass, Vomiting, Nausea, Anaemia, Nephropathy Toxic, Folate Deficiency, Iron Deficiency, Herpes Zoster, Vitamin B12 Increased, Asthenia, Beta 2 Microglobulin Increased, Leukopenia

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Lymphoma
    Start date: 2011-06-22
    End date: 2011-10-27

Doxorubicin Hydrochloride
    Indication: Lymphoma
    Start date: 2011-06-22
    End date: 2011-10-27

Prednisone
    Administration route: Oral
    Indication: Lymphoma
    Start date: 2011-06-22
    End date: 2011-10-27

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-06-22
    End date: 2011-10-27

Vincristine
    Indication: Lymphoma
    Start date: 2011-06-22
    End date: 2011-10-27

Other drugs received by patient: Heviran; Tamoxifen Citrate



Possible Vincristine side effects in female

Reported by a physician from United Kingdom on 2012-07-27

Patient: female, weighing 53.0 kg (116.6 pounds)

Reactions: Anaemia, Neutropenia, Hypokalaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-23

Doxorubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-23

Furosemide

Prednisone
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-23

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-23



Possible Vincristine side effects in male

Reported by a physician from United States on 2012-07-27

Patient: male

Reactions: Tinnitus, Femur Fracture, Oral Cavity Fistula, Osteomyelitis, Erectile Dysfunction, Neurotoxicity, Hypoaesthesia Oral, Carpal Tunnel Syndrome, Radiculopathy, Intervertebral Disc Protrusion, Cellulitis, Gingival Bleeding, Pneumonia, Anaemia, Encephalopathy, Otitis Externa, Abscess JAW, Nasal Septum Deviation, Paraesthesia, Rhinitis Allergic, Osteosclerosis, Osteonecrosis, Mental Disorder, Osteoporosis, Pain, Multiple Myeloma, Periodontitis, Neuropathy Peripheral, Overdose, Intervertebral Disc Degeneration, Injury, Depression, Gastrooesophageal Reflux Disease, Pain in JAW, Spondylolysis, Hepatitis Acute, Spondylolisthesis, Febrile Neutropenia, Osteolysis, Cognitive Disorder, Amnesia, Deformity, Osteoarthritis, Anxiety, Osteonecrosis of JAW, Infection

Drug(s) suspected as cause:
Aredia

Thalidomide
    Dosage: 50 mg, qd

Vincristine

Zometa
    Dosage: 4 mg, qmo

Other drugs received by patient: Clonazepam; Neurontin; Oxycontin; Tegretol; Dexamethasone



Possible Vincristine side effects in

Reported by a physician from Italy on 2012-07-27

Patient:

Reactions: Anaemia, Skin Toxicity, Febrile Neutropenia, Mucosal Inflammation, Neurotoxicity, Respiratory Failure, Sepsis, Neutropenia, Cardiotoxicity, Septic Shock, Thrombocytopenia, Myocardial Infarction, Diffuse Large B-Cell Lymphoma

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma

Epirubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma

Mabthera
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone and Prednisone
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma



Possible Vincristine side effects in female

Reported by a consumer/non-health professional from United Kingdom on 2012-07-23

Patient: female, weighing 67.0 kg (147.4 pounds)

Reactions: Small Intestinal Obstruction, Anaemia, Febrile Neutropenia, Device Related Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Start date: 2012-04-26

Doxorubicin HCL
    Start date: 2012-04-26

Prednisolone
    Administration route: Oral
    Start date: 2012-04-26

Vincristine
    Start date: 2012-04-26



Possible Vincristine side effects in male

Reported by a lawyer from United States on 2012-07-20

Patient: male

Reactions: Femur Fracture, Tinnitus, Osteomyelitis, Oral Cavity Fistula, Erectile Dysfunction, Neurotoxicity, Hypoaesthesia Oral, Intervertebral Disc Protrusion, Cellulitis, Pneumonia, Anaemia, Otitis Externa, Abscess JAW, Nasal Septum Deviation, Paraesthesia, Osteonecrosis, Rhinitis Allergic, Mental Disorder, Pain, Multiple Myeloma, Periodontitis, Overdose, Neuropathy Peripheral, Intervertebral Disc Degeneration, Injury, Depression, Gastrooesophageal Reflux Disease, Pain in JAW, Spondylolysis, Spondylolisthesis, Hepatitis Acute, Febrile Neutropenia, Osteolysis, Deformity, Amnesia, Osteoarthritis, Osteonecrosis of JAW, Infection

Drug(s) suspected as cause:
Aredia

Thalidomide
    Dosage: 50 mg, qd

Vincristine

Zometa
    Dosage: 4 mg, qmo

Other drugs received by patient: Neurontin; Clonazepam; Oxycontin; Dexamethasone; Tegretol



Possible Vincristine side effects in

Reported by a physician from Italy on 2012-07-20

Patient:

Reactions: Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Diffuse Large B-Cell Lymphoma Recurrent, Mucosal Inflammation, Neurotoxicity, Sepsis, Adverse Event, Cardiotoxicity, Neutropenia, Thrombocytopenia, Diffuse Large B-Cell Lymphoma, Lymphoma, Septic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 750 mg/m2 on day 1 for chop and 750 mg/m2 on day 2 for r-chop
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Dosage: 50 mg/m2 on day 1 for chop and 50 mg/m2 on day 2 for r-chop
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Dosage: 100 mg on days 1-5 for chop and r-chop
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: 375 mg/m2 on day 1 for r-chop
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Dosage: 1.4 mg/m2 on day 1 for chop and 1.4 mg/m2 on day 2 for r-chop upto a maximum dose of 2 mg
    Indication: Diffuse Large B-Cell Lymphoma

Other drugs received by patient: Neupogen



Possible Vincristine side effects in male

Reported by a consumer/non-health professional from Germany on 2012-07-09

Patient: male

Reactions: Anaemia, Febrile Neutropenia, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1500 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-04-03

Doxorubicin HCL
    Dosage: 100 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-04-03

Neulasta
    Dosage: 6 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-04-06
    End date: 2012-04-06

Prednisolone
    Dosage: 500 mg, qd
    Administration route: Oral
    Indication: B-Cell Lymphoma
    Start date: 2012-04-02
    End date: 2012-04-06

Rituximab
    Dosage: 750 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-02
    End date: 2012-04-02

Vincristine
    Dosage: 2 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-04-03

Other drugs received by patient: Novalgin / 00169801 /; Morphine Sulfate; Pantoprazole; Dipyrone TAB; Metoclopramide; Acyclovir



Possible Vincristine side effects in female

Reported by a consumer/non-health professional from Germany on 2012-07-06

Patient: female, weighing 70.0 kg (154.0 pounds)

Reactions: B-Cell Lymphoma, Anaemia, Urinary Incontinence, Abnormal Behaviour, Pulmonary Embolism, Cognitive Disorder, Pyrexia, Fall, Peripheral Sensory Neuropathy, Post Transplant Lymphoproliferative Disorder, Klebsiella Infection, Cytokine Release Syndrome, Cytomegalovirus Infection, Neutrophil Toxic Granulation Present, Traumatic Haematoma, Deep Vein Thrombosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, bid
    Start date: 2009-07-23

Campath
    Dosage: 20 mg, qd
    Start date: 2009-07-07

Campath
    Dosage: 30 mg, qd
    Start date: 2009-08-06
    End date: 2009-08-06

Campath
    Dosage: 30 mg, qd
    Start date: 2009-09-11
    End date: 2009-10-22

Campath
    Dosage: 10 mg, qd
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-07-23

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-08-20

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-07-21

Cyclophosphamide
    Dosage: 1250 mg, once
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-09-08
    End date: 2009-09-08

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-07-07

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-08-06
    End date: 2009-08-20

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-07-07

Doxorubicin HCL
    Dosage: 80 mg, once
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-07-21

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-08-06
    End date: 2009-08-20

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-09-08
    End date: 2009-09-08

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-07-23

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-08-20

Filgrastim
    Dosage: 3000 iu, unk
    Start date: 2009-07-26
    End date: 2009-08-27

Filgrastim
    Dosage: unk on days 4 through 13 of course 5
    Start date: 2009-08-20

Filgrastim
    Dosage: unk on days 4 through 12 of course 6
    Start date: 2009-09-08

Filgrastim
    Dosage: unk on days 4, 5, 6 of course 1
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Filgrastim
    Dosage: unk on days 4 through 15 of course 2
    Start date: 2009-07-07

Filgrastim
    Dosage: unk on days 4 through 8 and day 13 of course 3
    Start date: 2009-07-23

Filgrastim
    Dosage: unk on days 6 + 7 and days 9 through 12 of course 4
    Start date: 2009-08-06

Filgrastim
    Dosage: 30000 iu, qd
    Start date: 2009-09-11
    End date: 2009-09-19

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-06-23

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-09-11

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-07-07

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-15

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-08-06
    End date: 2009-08-10

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-07-23

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2009-09-08
    End date: 2009-09-08

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-06-23

Vincristine
    Dosage: 1 mg, once
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-15

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-08-20

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-07-23

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-07-07

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-07-21

Vincristine

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-08-06
    End date: 2009-08-20

Other drugs received by patient: Enoxaparin Sodium; Enoxaparin Sodium; Ganciclovir; Metoprolol Tartrate; Trimethoprim + Sulfamethoxazole; Dexamethasone; Antibiotics; Torsemide; Fluticasone Propionate W; Fondaparinux Sodium; Pantoprazole; Ganciclovir; Spiriva



Possible Vincristine side effects in 65 year old female

Reported by a physician from Netherlands on 2012-07-06

Patient: 65 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1310 mg, unk
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-25

Doxorubicin HCL
    Dosage: 88 mg, unk
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-25

Neulasta
    Dosage: 6 mg, unk
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-26

Rituximab
    Dosage: 660 mg, unk
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-25

Vincristine
    Dosage: 2 mg, unk
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-25



Possible Vincristine side effects in

Reported by a physician from South Africa on 2012-07-05

Patient:

Reactions: Pneumonia, Hepatotoxicity, Anaemia, Tuberculosis, Hyponatraemia, Kaposi's Sarcoma, Thrombocytopenia, Generalised Oedema

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: 10 u/m2
    Indication: Kaposi's Sarcoma AIDS Related

Doxorubicin HCL
    Indication: Kaposi's Sarcoma AIDS Related

Etoposide
    Dosage: 50-100 mg for 1-21 days of a 28 day cycle.
    Administration route: Oral
    Indication: Kaposi's Sarcoma AIDS Related

Lamivudine Stavudine Nevirapine
    Indication: Kaposi's Sarcoma AIDS Related

Vincristine
    Dosage: capped at 2 mg
    Indication: Kaposi's Sarcoma AIDS Related



Possible Vincristine side effects in 69 year old male

Reported by a individual with unspecified qualification from Germany on 2012-07-03

Patient: 69 year old male

Reactions: Anaemia, Febrile Neutropenia, Asthenia, Fall

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma

Mabthera
    Indication: non-Hodgkin's Lymphoma

Prednisone
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Indication: non-Hodgkin's Lymphoma



Possible Vincristine side effects in male

Reported by a physician from United States on 2012-07-03

Patient: male

Reactions: Femur Fracture, Tinnitus, Osteomyelitis, Oral Cavity Fistula, Erectile Dysfunction, Neurotoxicity, Hypoaesthesia Oral, Pneumonia, Cellulitis, Anaemia, Otitis Externa, Nasal Septum Deviation, Paraesthesia, Osteonecrosis, Rhinitis Allergic, Mental Disorder, Pain, Multiple Myeloma, Periodontitis, Overdose, Neuropathy Peripheral, Intervertebral Disc Degeneration, Injury, Depression, Gastrooesophageal Reflux Disease, Pain in JAW, Spondylolisthesis, Hepatitis Acute, Febrile Neutropenia, Osteolysis, Deformity, Amnesia, Osteoarthritis, Osteonecrosis of JAW, Infection

Drug(s) suspected as cause:
Aredia

Thalidomide
    Dosage: 50 mg, qd

Vincristine

Zometa
    Dosage: 4 mg, qmo

Other drugs received by patient: Dexamethasone; Tegretol; Oxycontin; Clonazepam; Neurontin



Possible Vincristine side effects in 67 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02

Patient: 67 year old male

Reactions: Weight Decreased, Anaemia, Acute Phosphate Nephropathy, Mental Status Changes, Hypercalcaemia, Hyperuricaemia, Haemodialysis, Tumour Lysis Syndrome, Renal Impairment, Oliguria, Leukocytosis, Thrombocytopenia, Decreased Appetite, Renal Failure Acute, Hepatosplenomegaly

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Chemotherapy

Dexamethasone Sodium Phosphate
    Indication: Chemotherapy

Doxorubicin HCL
    Indication: Chemotherapy

Vincristine
    Indication: Chemotherapy



Possible Vincristine side effects in male

Reported by a physician from United States on 2012-06-26

Patient: male

Reactions: Tinnitus, Femur Fracture, Oral Cavity Fistula, Osteomyelitis, Erectile Dysfunction, Neurotoxicity, Hypoaesthesia Oral, Cellulitis, Pneumonia, Anaemia, Otitis Externa, Nasal Septum Deviation, Paraesthesia, Osteonecrosis, Rhinitis Allergic, Mental Disorder, Pain, Multiple Myeloma, Overdose, Neuropathy Peripheral, Intervertebral Disc Degeneration, Injury, Depression, Gastrooesophageal Reflux Disease, Pain in JAW, Spondylolisthesis, Hepatitis Acute, Febrile Neutropenia, Osteolysis, Amnesia, Deformity, Osteoarthritis, Osteonecrosis of JAW, Infection

Drug(s) suspected as cause:
Aredia

Thalidomide
    Dosage: 50 mg, qd

Vincristine

Zometa
    Dosage: 4 mg, qmo

Other drugs received by patient: Tegretol; Clonazepam; Neurontin; Oxycontin; Dexamethasone



Possible Vincristine side effects in

Reported by a individual with unspecified qualification from Korea, Republic of on 2012-06-26

Patient:

Reactions: Abdominal Pain, Hyperbilirubinaemia, Anaemia, Alanine Aminotransferase Increased, Febrile Neutropenia, Rash, Pyrexia, Peripheral Sensory Neuropathy, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Asthenia, Thrombocytopenia

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: given on day 1 of each cycle
    Indication: B-Cell Lymphoma

Mabthera
    Dosage: on day 1 of every cycle
    Indication: B-Cell Lymphoma

Prednisolone
    Dosage: given on days 1 to 5 of every cycle (repeated every 3 weeks)
    Administration route: Oral
    Indication: B-Cell Lymphoma

Vincristine
    Dosage: given on day 1 of every cycle; dose: 1.4 mg/m2 ( maximum 2.0 mg)
    Indication: B-Cell Lymphoma



Possible Vincristine side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-18

Patient: male

Reactions: Tinnitus, Femur Fracture, Pain, Oral Cavity Fistula, Osteomyelitis, Multiple Myeloma, Erectile Dysfunction, Neurotoxicity, Hypoaesthesia Oral, Neuropathy Peripheral, Overdose, Intervertebral Disc Degeneration, Injury, Depression, Gastrooesophageal Reflux Disease, Pneumonia, Cellulitis, Hepatitis Acute, Spondylolisthesis, Anaemia, Febrile Neutropenia, Otitis Externa, Osteolysis, Deformity, Nasal Septum Deviation, Paraesthesia, Osteoarthritis, Osteonecrosis, Rhinitis Allergic, Osteonecrosis of JAW, Mental Disorder, Infection

Drug(s) suspected as cause:
Aredia

Thalidomide
    Dosage: 50 mg, qd

Vincristine

Zometa
    Dosage: 4 mg, qmo

Other drugs received by patient: Clonazepam; Oxycontin; Neurontin; Dexamethasone; Tegretol



Possible Vincristine side effects in male

Reported by a physician from Italy on 2012-06-14

Patient: male

Reactions: Epstein-Barr Virus Infection, Anaemia, Cytomegalovirus Infection, Neutropenia, Thrombocytopenia, Disease Progression, Infection

Drug(s) suspected as cause:
Carboplatin
    Indication: Burkitt's Lymphoma

Carmustine
    Indication: Burkitt's Lymphoma

Cisplatin
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Indication: Burkitt's Lymphoma

Etoposide
    Indication: Burkitt's Lymphoma

Granulocyte Colony Stimulating Factor
    Indication: Burkitt's Lymphoma

Ifosfamide
    Indication: Burkitt's Lymphoma

Melphalan Hydrochloride
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Burkitt's Lymphoma

Methylprednisolone
    Indication: Burkitt's Lymphoma

Radiotherapy
    Indication: Burkitt's Lymphoma

Rituximab
    Indication: Burkitt's Lymphoma

Unknown Medication
    Dosage: antimicrobial prophylaxis
    Indication: Burkitt's Lymphoma

Vincristine
    Indication: Burkitt's Lymphoma

Other drugs received by patient: Unknown Medication



Possible Vincristine side effects in

Reported by a individual with unspecified qualification from United States on 2012-06-11

Patient:

Reactions: Nausea, Bacteraemia, Anaemia, Hypoalbuminaemia, Abscess, Neutropenia, Thrombocytopenia, Decreased Appetite

Drug(s) suspected as cause:
Azacitidine

Azacitidine
    Indication: Lymphoma

Cyclophosphamide
    Dosage: for 6 to 9 days
    Indication: Lymphoma

Mabthera
    Dosage: for 8 days
    Indication: Lymphoma

Vincristine
    Dosage: for 8 days
    Indication: Lymphoma



Possible Vincristine side effects in 17 year old female

Reported by a physician from United States on 2012-06-08

Patient: 17 year old female, weighing 47.6 kg (104.7 pounds)

Reactions: Blood Bilirubin Increased, Pyrexia, Caecitis, Loss of Consciousness, Oedema Peripheral, Pulmonary Oedema, Hypocalcaemia, Acute Respiratory Distress Syndrome, Melaena, Hypertriglyceridaemia, Epistaxis, Dysphagia, Anaemia, Hyperglycaemia, General Physical Health Deterioration, Eating Disorder, Tremor, Cerebral Infarction, Depressed Level of Consciousness, Neutropenia, Confusional State, Dyskinesia, Somnolence, Splenic Infarction, Hypokalaemia, Pleural Effusion, White Blood Cell Count Decreased, Cerebrovascular Accident, Ascites, Diarrhoea, Hypophagia, Hypoalbuminaemia, Sinus Tachycardia, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1000mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Cytarabine
    Dosage: 75mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Dalteparin Sodium
    Indication: Product Used FOR Unknown Indication

Mercaptopurine
    Dosage: 60mgm2 cyclic
    Administration route: Oral
    Indication: T-Cell Type Acute Leukaemia

Methotrexate
    Indication: T-Cell Type Acute Leukaemia

Nelarabine
    Dosage: 650mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2012-04-13

Oncaspar
    Indication: T-Cell Type Acute Leukaemia

Vincristine
    Dosage: 1.5mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Other drugs received by patient: Nystatin; Lansoprazole; Insulin Aspart; Piperacillin and Tazobactam; Vancomycin; Voriconazole



Possible Vincristine side effects in male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-07

Patient: male, weighing 76.0 kg (167.2 pounds)

Reactions: Pneumonia, Anaemia, Febrile Neutropenia, Gastritis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Start date: 2012-01-19

Doxorubicin HCL
    Start date: 2012-01-19

Prednisone TAB
    Administration route: Oral
    Start date: 2012-01-18

Vincristine
    Start date: 2012-01-19



Possible Vincristine side effects in female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-06

Patient: female, weighing 67.0 kg (147.4 pounds)

Reactions: Anaemia, Febrile Neutropenia, Device Related Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Start date: 2012-04-26

Doxorubicin HCL
    Start date: 2012-04-26

Prednisolone
    Administration route: Oral
    Start date: 2012-04-26

Vincristine
    Start date: 2012-04-26



Possible Vincristine side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-05

Patient: male, weighing 102.6 kg (225.7 pounds)

Reactions: Cardio-Respiratory Arrest, Respiratory Failure, Anaemia, Troponin I Increased, Thrombocytopenia, Infection

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Adriamycin PFS
    Dosage: 101 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-05
    End date: 2011-07-05

Cyclophosphamide
    Dosage: 603 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-02
    End date: 2011-07-04

Cytarabine
    Dosage: 6 g, cyclic
    Indication: Mantle Cell Lymphoma
    End date: 2011-07-30

Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: 20 unk, unk
    Administration route: Oral
    End date: 2011-07-15

Methotrexate
    Dosage: 1600 mg, cyclic
    End date: 2011-07-28

Methotrexate
    Dosage: 400 mg, cyclic
    Indication: Mantle Cell Lymphoma
    End date: 2011-07-27

Rituximab
    Dosage: 750 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-01
    End date: 2011-07-26

Velcade
    Dosage: 2.6 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-01
    End date: 2011-07-26

Vincristine
    Dosage: 2 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-05
    End date: 2011-07-12

Other drugs received by patient: Filgrastim; Ferrous Sulfate TAB; Heparin; Senokot; Triamcinolone Acetonide; Compazine; Ciprofloxacin; Fluconazole; Omeprazole; Mesna; Prevident; Valtrex; Vitamin C / 00008001 /; Methylprednisolone; Periogard; Ultram; Vitamin D



Possible Vincristine side effects in

Reported by a physician from Germany on 2012-06-01

Patient:

Reactions: Respiratory Disorder, Pain, Myelodysplastic Syndrome, Pyrexia, Neoplasm, Death, Completed Suicide, Thrombocytopenia, Vomiting, Nausea, Anaemia, Acute Myeloid Leukaemia, Toxicity To Various Agents, Haematotoxicity, Hodgkin's Disease, Mucosal Inflammation, Accident, Alopecia, Gastrointestinal Disorder, Nervous System Disorder, non-Hodgkin's Lymphoma, Cardiovascular Disorder, Leukopenia, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: Hodgkin's Disease

Cyclophosphamide
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease

Prednisone TAB
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Indication: Hodgkin's Disease

Vincristine
    Indication: Hodgkin's Disease

Other drugs received by patient: Radiotherapy



Possible Vincristine side effects in 77 year old male

Reported by a physician from Denmark on 2012-05-29

Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)

Reactions: Fatigue, Malaise, Diarrhoea, Anaemia, Dizziness, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1612 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Doxorubicin HCL
    Dosage: 107 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Neulasta
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-26

Prednisolone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Rituximab
    Dosage: 750 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Other drugs received by patient: Pinex; Sulphamethizole; Valacyclovir Hydrochloride; Omeprazole



Possible Vincristine side effects in 18 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-28

Patient: 18 year old female

Reactions: Oligohydramnios, Normal Newborn, Anaemia, Febrile Neutropenia, Neutropenia, Pregnancy, Thrombocytopenia

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1 df: 2.2g/m2
    Indication: Rhabdomyosarcoma

Dactinomycin
    Dosage: q21d
    Indication: Rhabdomyosarcoma

Mesna
    Indication: Rhabdomyosarcoma

Neupogen
    Indication: Rhabdomyosarcoma

Vincristine
    Indication: Rhabdomyosarcoma



Possible Vincristine side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-28

Patient: female

Reactions: Foetal Growth Restriction, Premature Baby, Anaemia, Thrombocytopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cyclophosphamide

Doxorubicin HCL

Ifosfamide
    Dosage: 1df= 9g/m3 over 5 days.
    Indication: Ewing's Sarcoma

Vincristine



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017